(Q53327434)
Statements
The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease. (English)
Bodick NC
Offen WW
Shannon HE
Satterwhite J
Lucas R
van Lier R
Paul SM
1 January 1997
11 Suppl 4
S16-22